Literature DB >> 23820422

Expression of neuronal markers in the endometrium of women with and those without endometriosis.

T A Newman1, J L Bailey, L J Stocker, Y L Woo, N S Macklon, Y C Cheong.   

Abstract

STUDY QUESTION: How do the expression patterns of neuronal markers differ in the endometrium of women with and without endometriosis? SUMMARY ANSWER: The neuronal markers, PGP9.5, NGFp75 and VR1, are expressed in the endometrium at levels that do not differ between women with and without endometriosis. WHAT IS KNOWN ALREADY: Aberrant neuronal growth within the uterus may contribute to abnormal fertility and uterine dysfunction. However, controversy still exists as to whether aberrant innervation in the endometrium is associated with gynaecological pathology such as endometriosis. This may reflect the use of subjective methods such as histology to assess the innervation of the endometrium. We, therefore, employed a quantitative method, western blotting, to study markers of endometrial innervation in the presence and absence of endometriosis. STUDY DESIGN, SIZE, DURATION: This study included 45 women undergoing laparoscopic examination for the diagnosis of endometriosis. Endometrial samples were analysed by western blot for the expression of neuronal and neurotrophic markers, PGP9.5, VR1 and NGFp75. PARTICIPANTS/MATERIALS, SETTINGS,
METHODS: Endometrial pipelle biopsies were obtained from patients with (n = 20, study group) and without (n = 25, control group) endometriosis. Tissue was analysed by immunohistochemistry and western blot analysis for the expression of pan-neuronal marker, PGP9.5, sensory nociceptive marker, TPVR1, and low-affinity neurotrophic growth factor receptor, NGFRp75. MAIN RESULTS AND THE ROLE OF CHANCE: PGP9.5, NGFp75 and VR1 were expressed in the endometrium of women, independent of the presence of endometriosis. Furthermore, the expression level of PGP9.5, VR1 and NGFp75 did not alter between the two cohorts of women. LIMITATIONS, REASONS FOR CAUTION: Studies of this nature are subject to the heterogeneous nature of patient population and tissue samples despite attempts to standardize these parameters. Hence, further studies using similar methodology will be required to confirm our results. WIDER IMPLICATIONS OF THE
FINDINGS: Our results highlight that sensory neuronal markers are present in women with and without endometriosis. Future work will assess what the targets of the endometrial nerves are and investigate their function, their impact on endometrial biology and, in particular, whether aberrant neuronal function, rather than the mere presence of neuronal function, could be the root cause of subfertility and/or pain affecting many endometriosis sufferers. Our results do not, however, confirm the previous paradigm of increased innervation in the endometrium of women with endometriosis, nor the use of nerve cell detection from pipelle biopsies to diagnose endometriosis.

Entities:  

Keywords:  endometrial pipelle biopsy; endometriosis; innervation; neurons; sensory

Mesh:

Substances:

Year:  2013        PMID: 23820422     DOI: 10.1093/humrep/det274

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  9 in total

1.  Cannabinoid-induced cell death in endometrial cancer cells: involvement of TRPV1 receptors in apoptosis.

Authors:  B M Fonseca; G Correia-da-Silva; N A Teixeira
Journal:  J Physiol Biochem       Date:  2018-02-13       Impact factor: 4.158

Review 2.  Endometrial biomarkers for the non-invasive diagnosis of endometriosis.

Authors:  Devashana Gupta; M Louise Hull; Ian Fraser; Laura Miller; Patrick M M Bossuyt; Neil Johnson; Vicki Nisenblat
Journal:  Cochrane Database Syst Rev       Date:  2016-04-20

3.  Seminal plasma induces global transcriptomic changes associated with cell migration, proliferation and viability in endometrial epithelial cells and stromal fibroblasts.

Authors:  Joseph C Chen; Brittni A Johnson; David W Erikson; Terhi T Piltonen; Fatima Barragan; Simon Chu; Nargis Kohgadai; Juan C Irwin; Warner C Greene; Linda C Giudice; Nadia R Roan
Journal:  Hum Reprod       Date:  2014-03-13       Impact factor: 6.918

Review 4.  Peripheral changes in endometriosis-associated pain.

Authors:  Matteo Morotti; Katy Vincent; Jennifer Brawn; Krina T Zondervan; Christian M Becker
Journal:  Hum Reprod Update       Date:  2014-05-23       Impact factor: 15.610

5.  The brain-uterus connection: brain derived neurotrophic factor (BDNF) and its receptor (Ntrk2) are conserved in the mammalian uterus.

Authors:  Jocelyn M Wessels; Liang Wu; Nicholas A Leyland; Hongmei Wang; Warren G Foster
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

6.  Multivariate analysis of traumatic brain injury: development of an assessment score.

Authors:  John E Buonora; Angela M Yarnell; Rachel C Lazarus; Michael Mousseau; Lawrence L Latour; Sandro B Rizoli; Andrew J Baker; Shawn G Rhind; Ramon Diaz-Arrastia; Gregory P Mueller
Journal:  Front Neurol       Date:  2015-03-30       Impact factor: 4.003

7.  Autoimmune Profiling Reveals Peroxiredoxin 6 as a Candidate Traumatic Brain Injury Biomarker.

Authors:  John E Buonora; Michael Mousseau; David M Jacobowitz; Rachel C Lazarus; Angela M Yarnell; Cara H Olsen; Harvey B Pollard; Ramon Diaz-Arrastia; Lawrence Latour; Gregory P Mueller
Journal:  J Neurotrauma       Date:  2015-09-11       Impact factor: 5.269

8.  Local upregulation of transient receptor potential ankyrin 1 and transient receptor potential vanilloid 1 ion channels in rectosigmoid deep infiltrating endometriosis.

Authors:  Noémi Bohonyi; Krisztina Pohóczky; Bálint Szalontai; Anikó Perkecz; Krisztina Kovács; Béla Kajtár; Lajos Orbán; Tamás Varga; Sarolta Szegedi; József Bódis; Zsuzsanna Helyes; Miklós Koppán
Journal:  Mol Pain       Date:  2017 Jan-Dec       Impact factor: 3.395

9.  Comparative transcriptome analysis between patient and endometrial cancer cell lines to determine common signaling pathways and markers linked to cancer progression.

Authors:  Madelaine J Cho-Clark; Gauthaman Sukumar; Newton Medeiros Vidal; Sorana Raiciulescu; Mario G Oyola; Cara Olsen; Leonardo Mariño-Ramírez; Clifton L Dalgard; T John Wu
Journal:  Oncotarget       Date:  2021-12-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.